Literature DB >> 20149075

Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism.

R H White1, S Murin, T Wun, B Danielsen.   

Abstract

SUMMARY
BACKGROUND: The incidence of recurrent venous thromboembolism (VTE) varies depending on the nature of the initial provoking risk factor(s).
OBJECTIVES: To compare the incidence and time course of recurrent VTE after unprovoked VTE vs. VTE provoked by nine different types of surgery.
METHODS: Retrospective analysis of linked California hospital and emergency department discharge records. Between 1997 and 2007, all surgery-provoked VTE cases had a first-time VTE event diagnosed within 60 days after undergoing a major operation. The incidence of recurrent VTE was compared during specified follow-up periods by matching each surgery-provoked case with three unprovoked cases based on age, race, gender, VTE event, calendar year and co-morbidity.
RESULTS: The 4-year Kaplan-Meier cumulative incidence of recurrent VTE was 14.7% (95%CI: 14.2-15.1) in the matched unprovoked VTE group vs. 7.6% (CI: 7.0-8.2) in 11 797 patients with surgery-provoked VTE (P < 0.001). The overall risk reduction was 48%, which ranged from 64% lower risk (P < 0.001) after coronary bypass surgery to 25% lower risk (P = 0.06) after disc surgery. The risk of recurrent VTE 1-5 years after the index event was significantly lower in the surgery group (HR = 0.47, CI: 0.41-0.53). Within the surgery-provoked group, the risk of recurrent VTE was similar in men and women (HR = 1.0, CI: 0.8-1.3).
CONCLUSIONS: The risk of recurrent VTE after surgery-provoked VTE was approximately 50% lower than after unprovoked VTE, confirming the view that provoked VTE is associated with a lower risk of recurrent VTE. However, there was appreciable heterogeneity in the relative risk of recurrent VTE associated with different operations.

Entities:  

Mesh:

Year:  2010        PMID: 20149075     DOI: 10.1111/j.1538-7836.2010.03798.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  7 in total

Review 1.  Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Authors:  Marc Alan Rodger; Gregoire Le Gal
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Predicting the risk of venous thromboembolism recurrence.

Authors:  John A Heit
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

Review 3.  Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Authors:  Marc Alan Rodger; Gregoire Le Gal
Journal:  Blood Adv       Date:  2018-11-13

Review 4.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

Review 5.  Assessing the risk of recurrent venous thromboembolism--a practical approach.

Authors:  Jennifer Fahrni; Marc Husmann; Silvia B Gretener; Hong H Keo
Journal:  Vasc Health Risk Manag       Date:  2015-08-17

Review 6.  The epidemiology of venous thromboembolism.

Authors:  John A Heit; Frederick A Spencer; Richard H White
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

7.  Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism.

Authors:  Frederikus A Klok; Emilie Presles; Cecile Tromeur; Stefano Barco; Stavros V Konstantinides; Olivier Sanchez; Gilles Pernod; Leela Raj; Philippe Robin; Pierre-Yves Le Roux; Clément Hoffman; Solen Mélac; Laurent Bertoletti; Philippe Girard; Silvy Laporte; Patrick Mismetti; Guy Meyer; Christophe Leroyer; Francis Couturaud
Journal:  Res Pract Thromb Haemost       Date:  2019-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.